CD44 variant
1.Objective: To study the expression of Matrix metalloprateinase-9 (MMP9), E-cadherin (E-cad) and CD44 splice variant 6 (CD44v6) in oral squamous cell carcinoma (OSCC) and their relationships with clinical pathological characteristics and to investigate their roles in carcinogenesis, development, invasion and metastasis of OSCC.
